|
1
|
Foiselle M, Lajnef M, Hamdani N, Boukouaci W, Houbart C, Wu CL, Corvoisier PL, Barrau C, Yolken R, Moins-Teisserenc H, Leboyer M, Tamouza R. T-cell subset phenotypes in patients with bipolar disorder or schizophrenia with history of childhood maltreatment. Journal of Affective Disorders Reports 2023. [DOI: 10.1016/j.jadr.2023.100541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/03/2023] Open
|
|
2
|
Galadari A, Ram-Wolff C, Al Hage J, Battistella M, Vignon-Pennamen MD, Rivet J, Cayuela JM, Gabison G, Moins-Teisserenc H, Mourah S, Ingen-Housz-Oro S, Le Corre Y, Bagot M, de Masson A. Cutaneous Gamma Delta T-Cell Lymphoma with indolent evolution: A series of five cases. J Eur Acad Dermatol Venereol 2022; 36:e715-e717. [PMID: 35535450 DOI: 10.1111/jdv.18204] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Accepted: 05/03/2022] [Indexed: 12/01/2022]
Affiliation(s)
- A Galadari
- Department of Dermatology, Saint-Louis Hospital, APHP, Paris, France
| | - C Ram-Wolff
- Department of Dermatology, Saint-Louis Hospital, APHP, Paris, France.,French Cutaneous Lymphomas Study Group, Paris, France
| | - J Al Hage
- Department of Dermatology, Saint-Louis Hospital, APHP, Paris, France
| | - M Battistella
- INSERM U976, Institut de Recherche Saint-Louis, Paris, France.,Université de Paris, Paris, France.,Department of Pathology, Saint-Louis Hospital, APHP, Paris, France.,French Cutaneous Lymphomas Study Group, Paris, France
| | - M D Vignon-Pennamen
- Department of Pathology, Saint-Louis Hospital, APHP, Paris, France.,French Cutaneous Lymphomas Study Group, Paris, France
| | - J Rivet
- Department of Pathology, Saint-Louis Hospital, APHP, Paris, France.,French Cutaneous Lymphomas Study Group, Paris, France
| | - J M Cayuela
- Université de Paris, Paris, France.,Laboratory of Hematology and EA3518, Saint-Louis Hospital, APHP, Paris, France
| | - G Gabison
- Department of Dermatology, Saint-Louis Hospital, APHP, Paris, France
| | - H Moins-Teisserenc
- Université de Paris, Paris, France.,Laboratory of Hematology and INSERM U1160, Saint-Louis Hospital, APHP, Paris, France
| | - S Mourah
- INSERM U976, Institut de Recherche Saint-Louis, Paris, France.,Université de Paris, Paris, France.,Department of Pharmacology and Tumor Genomics, Saint-Louis Hospital, Paris, France
| | - S Ingen-Housz-Oro
- Department of Dermatology, Henri Mondor Hospital, APHP, Créteil, France.,Univ Paris Est Créteil Epiderme, Créteil, France.,French Cutaneous Lymphomas Study Group, Paris, France
| | - Y Le Corre
- Department of Dermatology, Centre University Hospital of Angers, Angers, France.,French Cutaneous Lymphomas Study Group, Paris, France
| | - M Bagot
- Department of Dermatology, Saint-Louis Hospital, APHP, Paris, France.,INSERM U976, Institut de Recherche Saint-Louis, Paris, France.,Université de Paris, Paris, France.,French Cutaneous Lymphomas Study Group, Paris, France
| | - A de Masson
- Department of Dermatology, Saint-Louis Hospital, APHP, Paris, France.,INSERM U976, Institut de Recherche Saint-Louis, Paris, France.,Université de Paris, Paris, France.,French Cutaneous Lymphomas Study Group, Paris, France
| |
Collapse
|
|
3
|
Perisse E, Mageau A, Brandberg Y, Gardeur L, Gresteau V, Mroz A, Reversat M, Roullier E, Stojicic D, Belmir L, Leblanc C, Goulenok T, de Lastours V, Teixeira M, Moins-Teisserenc H, Sacré K. Attitude et croyances du personnel soignant en Médecine Interne vis-à-vis de la vaccination antigrippale saisonnière : étude transversale descriptive. Rev Med Interne 2022; 43:342-346. [DOI: 10.1016/j.revmed.2022.03.339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2021] [Revised: 03/12/2022] [Accepted: 03/20/2022] [Indexed: 10/18/2022]
|
|
4
|
Zimmermann C, Boisson M, Ram-Wolff C, Sadoux A, Louveau B, Vignon-Pennamen MD, Rivet J, Cayuela JM, Dobos G, Moins-Teisserenc H, Roelens M, Gruber A, Lebbé C, Bagot M, Battistella M, Mourah S, de Masson A. Diagnostic performance of high-throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma. Br J Dermatol 2021; 185:679-680. [PMID: 33942285 DOI: 10.1111/bjd.20432] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2021] [Revised: 04/30/2021] [Accepted: 04/30/2021] [Indexed: 01/04/2023]
Affiliation(s)
- C Zimmermann
- Dermatology Department, APHP, Saint Louis Hospital, Paris, France.,INSERM U976 'Human Immunology, Pathophysiology and Immunotherapy', Institut de Recherche Saint Louis, Paris, France.,Université de Paris, Paris, France
| | - M Boisson
- Tumor Genomics and Pharmacology Department, APHP, Saint Louis Hospital, Paris, France
| | - C Ram-Wolff
- Dermatology Department, APHP, Saint Louis Hospital, Paris, France
| | - A Sadoux
- Tumor Genomics and Pharmacology Department, APHP, Saint Louis Hospital, Paris, France
| | - B Louveau
- Tumor Genomics and Pharmacology Department, APHP, Saint Louis Hospital, Paris, France.,INSERM U976 'Human Immunology, Pathophysiology and Immunotherapy', Institut de Recherche Saint Louis, Paris, France.,Université de Paris, Paris, France
| | | | - J Rivet
- Pathology Department, APHP, Saint Louis Hospital, Paris, France
| | - J-M Cayuela
- Université de Paris, Paris, France.,Hematology Laboratory, Saint Louis Hospital, Paris, France.,EA3518, Saint Louis Hospital, Paris, France
| | - G Dobos
- Dermatology Department, APHP, Saint Louis Hospital, Paris, France.,INSERM U976 'Human Immunology, Pathophysiology and Immunotherapy', Institut de Recherche Saint Louis, Paris, France.,Université de Paris, Paris, France
| | - H Moins-Teisserenc
- Université de Paris, Paris, France.,Hematology Laboratory, Saint Louis Hospital, Paris, France.,INSERM U1160, Institut de Recherche Saint Louis, Paris, France
| | - M Roelens
- Université de Paris, Paris, France.,INSERM U1160, Institut de Recherche Saint Louis, Paris, France
| | - A Gruber
- Tumor Genomics and Pharmacology Department, APHP, Saint Louis Hospital, Paris, France
| | - C Lebbé
- Dermatology Department, APHP, Saint Louis Hospital, Paris, France.,INSERM U976 'Human Immunology, Pathophysiology and Immunotherapy', Institut de Recherche Saint Louis, Paris, France.,Université de Paris, Paris, France
| | - M Bagot
- Dermatology Department, APHP, Saint Louis Hospital, Paris, France.,INSERM U976 'Human Immunology, Pathophysiology and Immunotherapy', Institut de Recherche Saint Louis, Paris, France.,Université de Paris, Paris, France
| | - M Battistella
- Pathology Department, APHP, Saint Louis Hospital, Paris, France.,INSERM U976 'Human Immunology, Pathophysiology and Immunotherapy', Institut de Recherche Saint Louis, Paris, France.,Université de Paris, Paris, France
| | - S Mourah
- Tumor Genomics and Pharmacology Department, APHP, Saint Louis Hospital, Paris, France.,INSERM U976 'Human Immunology, Pathophysiology and Immunotherapy', Institut de Recherche Saint Louis, Paris, France.,Université de Paris, Paris, France
| | - A de Masson
- Dermatology Department, APHP, Saint Louis Hospital, Paris, France.,INSERM U976 'Human Immunology, Pathophysiology and Immunotherapy', Institut de Recherche Saint Louis, Paris, France.,Université de Paris, Paris, France
| |
Collapse
|
|
5
|
Dangien A, Ram-Wolff C, Brice P, Battistella M, Roelens M, Moins-Teisserenc H, Peffault de Latour R, Mourah S, Bouaziz JD, Lebbé C, De Masson A, Bagot M. Traitement par ifosfamide et étoposide des lymphomes T cutanés primitifs avancés et réfractaires. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
|
6
|
Darbord D, De Masson A, Ram-Wolff C, Roelens M, Cassius C, Le Buanec H, Moins-Teisserenc H, Bouaziz JD, Cardine AM, Mourah S, Bagot M, Battistella M. Pronotic et mécanisme des rashs associés au mogamulizumab dans les lymphomes T avancés. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
|
7
|
Dangien A, Ram-Wolff C, Brice P, Battistella M, Roelens M, Moins-Teisserenc H, Peffault de Latour R, Mourah S, Bouaziz JD, Lebbé C, Bagot M, de Masson A. Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas. Br J Dermatol 2020; 183:961-962. [PMID: 32407544 DOI: 10.1111/bjd.19220] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- A Dangien
- Dermatology, Saint-Louis Hospital, AP-HP, Paris, France
| | - C Ram-Wolff
- Dermatology, Saint-Louis Hospital, AP-HP, Paris, France
| | - P Brice
- Department of, Hematology, Saint-Louis Hospital, AP-HP, Paris, France
| | - M Battistella
- Department of, Pathology, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Paris, France.,Université de Paris, Paris, France
| | - M Roelens
- Université de Paris, Paris, France.,INSERM U1160, Paris, France
| | | | - R Peffault de Latour
- Department of, Hematology and Bone Marrow Transplant, Saint-Louis Hospital, AP-HP, Paris, France.,Université de Paris, Paris, France.,INSERM U1160, Paris, France
| | - S Mourah
- Department of Pharmacogenomics, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Paris, France.,Université de Paris, Paris, France
| | - J-D Bouaziz
- Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Paris, France.,Université de Paris, Paris, France
| | - C Lebbé
- Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Paris, France.,Université de Paris, Paris, France
| | - M Bagot
- Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Paris, France.,Université de Paris, Paris, France
| | - A de Masson
- Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.,INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Paris, France.,Université de Paris, Paris, France
| |
Collapse
|
|
8
|
Roelens M, De Masson A, Battistella M, Mourah S, Estevez MJ, Delyon J, Herms F, Ram-Wolff C, Lebbé C, Bagot M, Moins-Teisserenc H. Compartiments immuns malins, T bénins conventionnels et régulateurs chez 36 patients traités par mogamulizumab pour CTCL avancé. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
|
9
|
Dumont M, Ram-Wolff C, Roelens M, Brice P, Peffault de la Tour R, Battistella M, Madelaine I, Julie D, Herms F, Bouaziz JD, Moins-Teisserenc H, Lebbé C, De Masson A, Bagot M. Efficacité et tolérance de l’association brentuximab védotin et bendamustine dans les lymphomes T cutanés de stade avancé. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
|
10
|
Roelens M, de Masson A, Battistella M, Mourah S, Estevez M, Delyon J, Herms F, Ram-Wolff C, Lebbé C, Bagot M, Moins-Teisserenc H. Malignant, benign conventional and regulatory T immune compartments in 36 patients treated with mogamulizumab for advanced CTCL. Eur J Cancer 2019. [DOI: 10.1016/s0959-8049(19)30522-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
|
11
|
Moins-Teisserenc H, Roelens M, Ram-Woff C, De Masson A, Maki G, Bensussan A, Toubert A, Bagot M. Ré-évaluation de la classification sanguine du mycosis fongoïde et du syndrome de Sézary à l’aide du marqueur KIR3DL2/CD158k. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
|
12
|
Hurabielle C, Sicre de Fontbrune F, Moins-Teisserenc H, Robin M, Jachiet M, Coman T, Dhedin N, Cassius C, Chasset F, de Masson A, Michonneau D, Bagot M, Bergeron A, Socié G, Peffault de Latour R, Bouaziz JD. Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease. Br J Dermatol 2017; 177:e206-e208. [PMID: 28422274 DOI: 10.1111/bjd.15593] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- C Hurabielle
- Service de Dermatologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France
| | | | - H Moins-Teisserenc
- Service d'Immunobiologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France.,Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
| | - M Robin
- Service d'Hématologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France
| | - M Jachiet
- Service de Dermatologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France
| | - T Coman
- Service d'Hématologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France
| | - N Dhedin
- Service d'Hématologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France
| | - C Cassius
- Service de Dermatologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France
| | - F Chasset
- Service de Dermatologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France
| | - A de Masson
- Service de Dermatologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France
| | - D Michonneau
- Service d'Hématologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France
| | - M Bagot
- Service de Dermatologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France.,Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
| | - A Bergeron
- Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France.,Service de Pneumologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France
| | - G Socié
- Service d'Hématologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France.,Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
| | - R Peffault de Latour
- Service d'Hématologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France.,Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
| | - J-D Bouaziz
- Service de Dermatologie, AP-HP, Hôpital Saint-Louis, Paris, 75010, France.,Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
| |
Collapse
|
|
13
|
Hurabielle C, Fontbrune FSD, Robin M, Moins-Teisserenc H, Coman T, Jachiet M, Cassius C, Chasset F, Bagot M, Peffault de Latour R, Socié G, Bouaziz JD. Efficacité et tolérance du ruxolitinib (JAKAVI) dans la GVH cutanée chronique sclérodermiforme cortico-résistante. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
|
14
|
Arruda LCM, Clave E, Moins-Teisserenc H, Douay C, Farge D, Toubert A. Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases. Curr Res Transl Med 2016; 64:107-13. [PMID: 27316394 DOI: 10.1016/j.retram.2016.03.004] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2016] [Accepted: 03/31/2016] [Indexed: 12/21/2022]
Abstract
Autologous hematopoietic stem cell transplantation (AHSCT) is currently investigated as treatment for severe and refractory autoimmune diseases, such as multiple sclerosis (MS), systemic sclerosis (SSc), Crohn's disease (CD) and systemic lupus erythematosus. Randomized clinical trials in MS, SSc and CD have shown the efficacy of AHSCT to promote control of disease activity and progression, when compared to conventional treatment. The use of high dose immunosuppressive conditioning is essential to eliminate the autoimmune repertoire, and the re-infusion of autologous hematopoietic stem cells avoids long-term leucopenia by reconstitution of both immune and hematological systems. Recent studies showed that AHSCT is able to deplete the autoimmune compartment and further promote the formation of a new auto-tolerant immune repertoire, reducing the inflammatory milieu and leading to long-term clinical remission without any complementary post-graft treatment. Deep knowledge about the mechanisms of action related to AHSCT-induced remission is required for the management of possible post-AHSCT relapse and improvement of clinical protocols. This paper will review the mechanisms enrolled in the immune response resetting promoted by AHSCT in patients with autoimmune diseases.
Collapse
Affiliation(s)
- L C M Arruda
- Center for Cell-based Therapy, São Paulo Research Foundation (FAPESP), Ribeirão Preto, Brazil; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
| | - E Clave
- Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France; INSERM UMR1160, Paris, France; Laboratoire d'Immunologie et d'Histocompatibilité, Hôpital Saint-Louis, AP-HP, Paris, France
| | - H Moins-Teisserenc
- Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France; INSERM UMR1160, Paris, France; Laboratoire d'Immunologie et d'Histocompatibilité, Hôpital Saint-Louis, AP-HP, Paris, France
| | - C Douay
- Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France; INSERM UMR1160, Paris, France; Laboratoire d'Immunologie et d'Histocompatibilité, Hôpital Saint-Louis, AP-HP, Paris, France
| | - D Farge
- Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France; INSERM UMR1160, Paris, France; Unité Clinique de Médecine Interne, Maladies Autoimmunes et Pathologie Vasculaire, UF 04, Hôpital Saint-Louis, AP-HP, Assistance Publique des Hôpitaux de Paris, 75010 Paris, France
| | - A Toubert
- Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France; INSERM UMR1160, Paris, France; Laboratoire d'Immunologie et d'Histocompatibilité, Hôpital Saint-Louis, AP-HP, Paris, France
| |
Collapse
|
|
15
|
Le Dorze M, Tarazona V, Brumpt C, Moins-Teisserenc H, Lukaszewicz AC, Payen D. Lymphocyte phenotype during severe sepsis and septic shock. Intensive Care Med Exp 2015. [PMCID: PMC4796538 DOI: 10.1186/2197-425x-3-s1-a622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
|
16
|
Santander S, Aoki M, Hernandez J, Pombo M, Moins-Teisserenc H, Mooney N, Fiorentino S. Galactomannan from Caesalpinia spinosa induces phenotypic and functional maturation of human dendritic cells. Int Immunopharmacol 2011; 11:652-60. [DOI: 10.1016/j.intimp.2011.01.006] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2010] [Revised: 12/24/2010] [Accepted: 01/04/2011] [Indexed: 10/18/2022]
|
|
17
|
Moins-Teisserenc H, Semana G, Alizadeh M, Loiseau P, Bobrynina V, Deschamps I, Edan G, Birebent B, Genetet B, Sabouraud O. TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosis. Hum Immunol 1995; 42:195-202. [PMID: 7759306 DOI: 10.1016/0198-8859(94)00093-6] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
MS is an autoimmune demyelinating disease that has been known to be associated with the HLA-DRB1*1501-DQA1*0102-DQB1*0602 haplotype. TAP1 and TAP2, two genes encoded within the MHC class II region between HLA-DP and -DQ loci, display genetic variability and are involved in the transport of antigenic peptides from the cytoplasm to the endoplasmic reticulum. Comparison of 116 MS patients with Caucasoid controls did not reveal any significant correlation between the previously described alleles of the TAP1 and TAP2 genes and MS. We report here an additional TAP2 dimorphism at codon 386, called I and J, corresponding to a silent mutation. An increased frequency of the J variant was observed in the patient population. The J mutation was not found in linkage disequilibrium with the HLA-DRB1*1501 allele and can be considered an additional genetic susceptibility marker of the disease.
Collapse
Affiliation(s)
- H Moins-Teisserenc
- Laboratory for Immunology and Histocompatibility, INSERM Unit 396, Saint Louis Hospital, Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
|
18
|
Affiliation(s)
- H Moins-Teisserenc
- Laboratoire d'Immunologie et d'Histocompatibilité, Unité I. N. S. E. R. M. 396, Hôpital Saint-Louis, Paris, France
| | | | | | | |
Collapse
|